MOUNTAIN VIEW, CA — (Marketwired) — 05/07/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today reported recent business highlights and financial results for the first quarter ended March 31, 2015.The Company reported revenues of $5.8 million in the first quarter, up 57% over the same period in the prior year.The Company sold five Magellan Robotic Systems in the first quarter of 2015 compared to two robotic systems in the first quarter of 2014.The volum
MOUNTAIN VIEW, CA — (Marketwired) — 04/22/15 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 2015 Charing Cross International Symposium April 28- May 1 at the Olympia Grand in London, UK. The company will highlight the Magellan 6Fr Robotic Catheter and the Magellan 10Fr Robotic Catheter, both of which have more recently received CE Mark.Hansen Medical expects that the Magellan Robotic
MOUNTAIN VIEW, CA — (Marketwired) — 04/14/15 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the Company–s Magellan 10Fr Robotic Catheter has received European Conformity (CE) Marking for use in the peripheral vasculature. Achieving this milestone allows the company to market the Magellan 10Fr Robotic Catheter in Europe and other countries that require the CE Mark.The Magellan 10Fr Robotic Catheter is the latest addition to the family
MOUNTAIN VIEW, CA — (Marketwired) — 03/10/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced that it has entered into a securities purchase agreement in connection with a private placement of convertible preferred stock and warrants to purchase common stock with investors associated with leading medical device executive Jack W. Schuler, Oracle Investment Management, Westwood Management, and other healthcare executives including Fred Moll, t
MOUNTAIN VIEW, CA — (Marketwired) — 02/26/15 — Hansen Medical®, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first clinical procedures with the Magellan Robotic System in the Middle East. The team led by Dr. Iyad Feteih, Interventional Radiologist and Assistant Hospital Director, performed five procedures with Magellan at King Fahd Hospital (MOH) in Jeddah, Kingdom of Saudi Arabia. The Magellan system was installed in late 2014 in
MOUNTAIN VIEW, CA — (Marketwired) — 02/23/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the fourth quarter and fiscal year ended December 31, 2014.The Company commercialized 3 Magellan Robotic systems in the fourth quarter and a total of 12 robotic systems in fiscal year 2014.The volume of catheters sold was up 40% in the fourth quarter over the same period in the prior year and up 11%
MOUNTAIN VIEW, CA — (Marketwired) — 02/11/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 40th Annual Society of Interventional Radiology (SIR) Scientific Meeting March 1 – March 4 at the Georgia World Congress Center in Atlanta, GA. The Company will showcase the Magellan 6Fr Robotic Catheter being used by Interventional Radiologists in embolization procedures, and will conduct Magellan Ro
MOUNTAIN VIEW, CA — (Marketwired) — 02/03/15 — Hansen Medical, Inc. (NASDAQ: HNSN) — An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting (February 28 – March 5, 2015, Atlanta, GA), found the use of the Magellan Robotic System in transarterial chemoembolization (TACE) procedures is feasible, and that remote robotic catheter navigation with Magellan leads to over 80% reduction in radiation dose to the operating physician when compared wit
